Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Net Income of -$50.34 million for fiscal year 2025.
LEXICON PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$50.34M | +74.9% |
| 2024 | -$200.40M | -13.1% |
| 2023 | -$177.12M | -73.7% |
| 2022 | -$101.94M | -16.2% |
| 2021 | -$87.76M | -49.8% |
| 2020 | -$58.57M | -145.0% |
| 2019 | $130.13M | +208.0% |
| 2018 | -$120.55M | +2.0% |
| 2017 | -$122.99M | +6.4% |
| 2016 | -$131.44M | -2707.5% |
| 2015 | -$4.68M | +95.3% |
| 2014 | -$100.29M | +3.7% |
| 2013 | -$104.13M | +5.5% |
| 2012 | -$110.21M | +5.2% |
| 2011 | -$116.22M | -14.2% |
| 2010 | -$101.78M | -22.9% |
| 2009 | -$82.78M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.77M | +80.3% | -492.7% |
| June 30, 2025 | $3.25M | +106.1% | +112.9% |
| March 31, 2025 | -$25.30M | +47.7% | +61.0% |
| September 30, 2024 | -$64.81M | -28.3% | -21.3% |
| June 30, 2024 | -$53.43M | -19.0% | -10.4% |
| March 31, 2024 | -$48.40M | -51.6% | +4.2% |
| September 30, 2023 | -$50.52M | -116.0% | -12.5% |
| June 30, 2023 | -$44.90M | -82.6% | -40.6% |
- LEXICON PHARMACEUTICALS, INC. showed an increase of +74.9% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, LEXICON PHARMACEUTICALS, INC.’s net income has grown by 39.2% (from -$82.78 million to -$50.34 million).
- The most recent figure is from LEXICON PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: